Domicilium Real Estate Fund III LP reported other involving 113,636 derivative units of Eloxx Pharmaceuticals, Inc. on May 27, 2026

Other
Form 4 code J. Other acquisition or disposition. The filer must describe the transaction.
10% owner
10%
Filed Jun 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
113,636Pre-funded Warrant
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
238,422Direct
Trade date
May 27, 2026Other
Filed
Jun 5, 2026, 10:44 AM ET9-day reporting delay
Accession
0000919574-26-003845Code J · Transaction 100508
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 27, 2026Other113,636$0.00$0Trade 100507
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
3 warnings
delayed filingThe filing was reported 9 calendar days after the transaction date.
missing priceThe filing did not provide a usable price per share.
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

ELOX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ELOX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Jun 12, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Pursuant to the terms of the pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants"), Domicilium Real Estate Fund III LP (the "Fund"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer. F2: These securities reflect a 11 for 1 reverse stock split effective May 29, 2026. F3: The securities are owned directly by the Fund and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (iii) Daniel Simon, the managing member of Domicilium and the General Partner. F4: The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium. F5: The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.